User Acceptance, Safety, and Effectiveness of The Postpartum Intrauterine Contraceptive Device
Keywords:
Intrauterine Devices, Birth Control, PPIUCDAbstract
Background: Reducing the rates of newborn and maternal mortality requires keeping a healthy distance between pregnancies and properly timing them. In addition to reducing poverty and hunger, family planning lowers the risk of 32% of maternal fatalities and 10% of child deaths. There is an increased risk of newborn morbidity and mortality when there are short gestational intervals. Condoms, intrauterine contraceptive devices (IUCD), injectable, oral contraceptive pills (OCPs), sterilization, and other treatments are readily available as short- and long-acting contraceptive methods. The most cost-effective long-term contraceptive alternative is the copper-containing intrauterine contraceptive device, or Cu IUCD. Cu IUCD is a reversible, non-hormonal contraceptive method that is safe to use while nursing and has a long effective life. Objective: To evaluate user acceptance, safety, and effectiveness of the Postpartum intrauterine contraceptive device. Study design: A prospective study Place and Duration This study was conducted in Bilawal Medical College CDF Hospital Hyderabad from October 2022 to October 2023 Methodology: A non-probability consecutive sampling strategy was used in the investigation. Every woman who visited antenatal clinics and was part of the study received counseling regarding several contemporary methods of contraception. A variety of contemporary contraceptive methods were offered to women, including IUCD, tubal ligation, implants, pills, and injectable. Those who opted for intrauterine contraceptive device insertion after giving birth had their choices tracked and documented. These women either had a cesarean delivery or a typical vaginal delivery. Results: A total of 250 patients were involved in this research. The average age of the patients was 27.1 years. Within 10 minutes of delivery of placenta, PPIUCD was inserted. A total of 212 women were multigravida while 38 were primigravida. There were no cases of perforation. Conclusion: Intrauterine devices placed after childbirth have shown to be a dependable, safe, reversible, and longacting means of birth control.
Downloads
References
Rehman M, Akhtar O, Yasmin H, Majid E. Acceptance of Postpartum
Intrauterine Contraceptive Device as a Method of Contraception in a
Tertiary Care Hospital, Karachi. Journal of The Society of
Obstetricians and Gynaecologists of Pakistan. 2022 Jun 8;12(2):91-4.
Ashraf S, Bashir M, Yousaf RT. In A Tertiary Care Hospital, the Use of A
Postpartum Intrauterine Contraceptive Device as A Method of
Contraception. Pakistan Journal of Medical & Health Sciences.
;16(ll):667-.
Faisal M, Naseer O, Khan N, Chaudhary R. Barriers in the use of post
partum intra uterine contraceptive device. J Soc Obstet Gynaecol
Pak. 2016;6(l):22-5.
Nisar N, Dars S, Awan S, Jokhio F. Post-partum intrauterine
contraceptive device: experience from tertiary care hospital in sindh
Province Pakistan. Journal of Liaquat University of Medical &
Health Sciences. 2020 Oct 5;19(03):162-6.
Nalini N, Singh B, Jha S, Singh AV. Acceptance, safety and efficacy of
postpartum intrauterine contraceptive device. Journal of Family
Medicine and Primary Care. 2023 May l;12(5):868-73.
Sultana R, Badar N, Usmani SS, Hafeez M. Womens Experience with
Postpartum Intrauterine Contraceptive Devke. Journal of The Sodety of
Obstetricians and Gynaecobgists of Pakistan. 2022 Sep 4;12(3):267-71.
Thota S, Nasreen MU, Ramadevi S, Himasree M. Study of acceptability
for the use of postpartum intrauterine contraceptive device among
women attending government general hospital, Guntur. New
Indian J OBGYN. 2022;8.
Taneja N, Gupta S, Kaur K. A retrospective study of post-partum intrauterine
contraceptive devices in a government maternity home of Delhi Int J
Reprod Contracept Obstet Gynecol 2020 Dec 1; 9:4932-6.
Fatima S, Rehman A, Ahmed Z, Sajid MM, Habiba U, Rehman A.
Postpartum Insertion of Intrauterine Contraceptive Device: A Safe
And Effective Contraception. Journal of Ayub Medical College
Abbottabad-Pakistan. 2022 Oct 2;34.
Jain R, Sharma M, Gupta S. Acceptance, safety and complications of
postpartum intra uterine contraceptive device: a prospective study in
tertiary care hospital. International Journal of Reproduction,
Contraception, Obstetrics and Gynecology. 2019 May 1;8(5):1916-21.
Anjum Afshan SSA. Immediate Postpartum IUCD insertion: An
opportunity not to be missed. Annals AbbasiShaheed Hospital and
Karachi Medical and Dental College. 2013 June 2014;19(l):5.
Eroglu K, Akkuzu G, Vural G, Dilbaz B, Akin A, Taskin L, et al.
Comparison of efficacy and complications of IUD insertion in
immediate postplacental/early postpartum period with interval
period: 1 year follow-up. Contraception. 2006 Nov;74(5):376-81.
PubMed PMID: 17046378.
Shukla M, Qureshi S, Chandrawati. Post-placental intrauterine device
insertion--a five-year experience at a tertiary care centre in north
India. The Indian journal ofmedical research. 2012 Sep;136(3):432-
PubMed PMID: 23041736. Pubmed Central PMCID: 3510889.
SZ Bhutta IB, Bano K. Insertion of intrauterine contraceptive device at
cesarean section. JCPSP. 2011;21(9):4. 2011.
Singal S, Bharti R, Dewan R, Divya, Dabral A, Batra A, et al. Clinical
Outcome of Postplacental Copper T 380A Insertion in Women
Delivering by Caesarean Section. Journal of clinical and diagnostic
research:JCDR. 2014 Sep;8(9): OC01-4. PubMed PMID: 25386484.
Pubmed Central PMCID: 4225936.
Studies Niop. Pakistan Demographic and Health Survey Islamabad:
National institute of population studies; 2017-2018. Available from:
Pakistan Demographic and Health Survey 2017- 18 [FR354]
(dhsprogram.com).
Balsarkar GD, Nayak A. Postpartum IUCD: Rediscovering a Languishing
Innovation. Journal of obstetrics and gynaecology of India. 2015
Jul;65(4):218-20. PubMed PMID: 26243985. Pubmed Central
PMCID: 4518011.
Ortiz ME, Croxatto HB, Bardin CW. Mechanisms of action of
intrauterine devices. Obstetrical & gynecological survey. 1996
Dec;51(12 Suppl): S42-51. PubMed PMID: 8972502.
Kaneshiro B, AebyT. Long-term safety,efficacy, and patient acceptability
of the intrauterine Copper T-380A contraceptive device.
International journal of women's health. 2010 Aug 09; 2:211-20.
PubMed PMID: 21072313. Pubmed Central PMCID: 2971735.
Cleland J, Bernstein S, Ezeh A, Faundes A, Glasier A, Innis J. Family
planning: the unfinished agenda. Lancet. 2006 Nov
;368(9549):1810-27. PubMed PMID: 17113431.
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
